カテゴリ： MarketLine, ドイツ, 企業調査

HeidelbergCement AG：戦略・SWOT・企業財務分析

◆英語タイトル：HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015303
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：42
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：建設・不動産
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

HeidelbergCement AG – Strategy, SWOT and Corporate Finance Report
Summary

HeidelbergCement AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

HeidelbergCement AG (HeidelbergCement) is a manufacturer of building materials, based in Germany. The company’s principal operations include production and distribution of cement and aggregates. The company focuses on the downstream activities, which include ready-mixed concrete, concrete products, building products and concrete elements. The company provides ready-mixed cement products for geotechnology, environmental technology and road construction. It provides aggregates useful for construction of infrastructure such as roads. The company also undertakes cement and coal trading activities through its subsidiaries, HC Trading and HC Fuels. The company operates 85 cement plants and operates in 2,100 locations across five continents. HeidelbergCement is headquartered in Heidelberg, Germany.

In October 2016, the company completed the acquisition of 100% interest in Italcementi S.p.A.

Scope

- Detailed information on HeidelbergCement AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting HeidelbergCement AG in the form of a SWOT analysis
- An in-depth view of the business model of HeidelbergCement AG including a breakdown and examination of key business segments
- Intelligence on HeidelbergCement AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about HeidelbergCement AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of HeidelbergCement AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess HeidelbergCement AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on HeidelbergCement AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
HeidelbergCement AG: Company Overview
HeidelbergCement AG: Overview and Key Facts
HeidelbergCement AG: Overview
HeidelbergCement AG: Key Facts
HeidelbergCement AG: Key Employees
HeidelbergCement AG: Key Employee Biographies
HeidelbergCement AG: Major Products and Services
HeidelbergCement AG: Company History
HeidelbergCement AG: Management Statement
HeidelbergCement AG: Locations and Subsidiaries
HeidelbergCement AG: Key Competitors
HeidelbergCement AG: Company Analysis
HeidelbergCement AG: Business Description
HeidelbergCement AG: SWOT Analysis
HeidelbergCement AG: SWOT Overview
HeidelbergCement AG: Strengths
HeidelbergCement AG: Weaknesses
HeidelbergCement AG: Opportunities
HeidelbergCement AG: Threats
HeidelbergCement AG: Corporate Financial Deals Activity
HeidelbergCement AG: Financial Deals Overview
HeidelbergCement AG: Targets and Partners
HeidelbergCement AG: Top Deals 2013 – 2017YTD*
HeidelbergCement AG: Advisors
HeidelbergCement AG: Top Legal Advisors
HeidelbergCement AG: Top Financial Advisors
HeidelbergCement AG: Mergers and Acquisitions
HeidelbergCement AG: Capital Raising
HeidelbergCement AG: Divestments
HeidelbergCement AG: Recent Developments
HeidelbergCement AG: News and Events Summary
HeidelbergCement AG: Corporate Governance
HeidelbergCement AG: Financial Performance
HeidelbergCement AG: Red Flags/DistressSignals
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: HeidelbergCement AG: Key Facts
Table 2: HeidelbergCement AG: Key Employees
Table 3: HeidelbergCement AG: Locations and Subsidiaries
Table 4: HeidelbergCement AG: Key Competitors
Table 5: HeidelbergCement AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: HeidelbergCement AG: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: HeidelbergCement AG: M&A Average Deal Size - Value (US$m)
Table 8: HeidelbergCement AG: Targets and Partners
Table 9: HeidelbergCement AG: Top Deals 2013 - 2017YTD*
Table 10: HeidelbergCement AG: Legal Advisor Ranking by Value (US$m)
Table 11: HeidelbergCement AG: Financial Advisor Ranking by Value (US$m)
Table 12: HeidelbergCement AG: M&A Volume and Value Trend (2013 - YTD*2017)
Table 13: HeidelbergCement AG: M&A Activity by Geography (2013 - YTD*2017)
Table 14: HeidelbergCement AG: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 15: HeidelbergCement AG: Capital Raising by Deal Type (2013 - YTD*2017)
Table 16: HeidelbergCement AG: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 17: HeidelbergCement AG: Divestments by Geography (2013 - YTD*2017)
Table 18: HeidelbergCement AG: News and Events Summary
Table 19: HeidelbergCement AG: Corporate Governance
Table 20: HeidelbergCement AG: Financial Performance
Table 21: HeidelbergCement AG: Red Flags/DistressSignals

★海外企業調査レポート[HeidelbergCement AG：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Indigo Biosciences Inc-製薬・医療分野：企業M&A・提携分析
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, …
  • Mitsui Chemicals Inc (4183)：企業の財務・戦略的SWOT分析
    Mitsui Chemicals Inc (4183) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Trimble Inc：企業の戦略・SWOT・財務情報
    Trimble Inc - Strategy, SWOT and Corporate Finance Report Summary Trimble Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hill-Rom Holdings Inc (HRC)-医療機器分野：企業M&A・提携分析
    Summary Hill-Rom Holdings Inc (Hill-Rom) is a medical technology company that offers patient support systems, surgical solutions and other front line care products. The company’s major products and services include patient care systems; safe mobility and handling solutions; non-invasive therapeutic …
  • Inivata Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotid …
  • Polaris Industries Inc.：企業の戦略・SWOT・財務分析
    Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Polaris Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Global Cardiovascular Innovation Center-医療機器分野：企業M&A・提携分析
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Fortune Electric Co Ltd (1519)：企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company provides products such as distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It …
  • Cadence Biomedical Inc-医療機器分野：企業M&A・提携分析
    Summary Cadence Biomedical Inc (Cadence), formerly Empowering Engineering Technologies Corp, is a medical device company that provides mobility products. The company offers product such as Kickstart walking system. It provides product to individuals with severe mobility impairments. Cadence’s produc …
  • Sinclair Oil Corporation：企業の戦略・SWOT・財務分析
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Oaktree Capital Group Llc：企業の戦略・SWOT・財務分析
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ELITechGroup Inc：企業の製品パイプライン分析2018
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • SoftBank Group Corp：企業の戦略・SWOT・財務情報
    SoftBank Group Corp - Strategy, SWOT and Corporate Finance Report Summary SoftBank Group Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • LG International Corp：企業のM&A・事業提携・投資動向
    LG International Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LG International Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Kodiak Sciences Inc-製薬・医療分野：企業M&A・提携分析
    Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC, is a drug company that discovers and develops new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes its proprietary Bioc …
  • Great Wolf Resorts Inc：企業の戦略・SWOT・財務情報
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • XBiotech Inc (XBIT)：企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)：企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Valeo Pharma Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Valeo Pharma Inc (Valeo Pharma), a subsidiary of Manitex Capital Inc, is a pharmaceutical company that offers healthcare solutions and specialty products. The company provides dermatology products such as drops, tablets, solutions, injections among others. It develops, licenses, and commerci …
  • The Jim Pattison Group：企業の戦略・SWOT・財務情報
    The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report Summary The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆